We preferred this strategy, rather than generating a novel Foxp3-DTR transgenic line directly on the NOD genetic background, because adult DEREG mice on a non-autoimmune prone genetic background have been shown to be resistant to autoimmune diseases or scurfy-like symptoms after DT treatment (9, 25, 26). Here, FOXP3 is linked to autoimmune disease.